Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy
- 31 December 1995
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (5) , 848-849
- https://doi.org/10.1016/0959-8049(95)00014-a
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- The Role of Retroperitoneal Lymphadenectomy in Clinical Stage B Testis Cancer: The Indiana University Experience (1965 to 1989)Journal of Urology, 1995
- Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumorsCancer, 1994
- Primary Retroperitoneal Lymph Node Dissection in Clinical Stage A Non‐seminomatous Germ Cell Testis Cancer Review of the Indiana University Experience 1965–1989British Journal of Urology, 1993
- Immediate Adjuvant Chemotherapy versus Observation with Treatment at Relapse in Pathological Stage II Testicular CancerNew England Journal of Medicine, 1987